Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: November 10, 2020
Reporting Period: Event date of November 10, 2020.
Context: The filing serves as a Regulation FD disclosure to announce upcoming investor and analyst presentations. It incorporates an investor presentation (Exhibit 99.1) intended for use by executive officers.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the existence of an investor presentation rather than a financial statement containing quantitative data.
Material Changes
No material financial changes or operational updates are detailed within the text of this specific Form 8-K. The filing references an attached presentation (Exhibit 99.1) for detailed data, but the content of that exhibit is not included in the provided source text.
Guidance, Outlook, and Risks
- Management Commentary: Executive officers intend to use the material in Exhibit 99.1 for upcoming presentations to investors and analysts.
- Legal Status of Information: The information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
- Emerging Growth Company: The registrant is identified as an emerging growth company.
Investor Verification Checklist
- Verify the contents of Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation data November 2020) for actual financial figures and guidance, as they are not present in the 8-K text.
- Confirm the dates and details of the upcoming investor presentations mentioned by executive officers.
- Note that the information in this filing is not legally "filed" under Section 18 of the Exchange Act, which may affect liability standards for the disclosed information.